PeproMene Bio, Inc. — Form D
PeproMene Bio, Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-12. The offering totals $40.2M, of which $40.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-06-12
- Form: D
- Accession: 0001214659-18-004400
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $40.2M
- Amount sold: $40.2M
- Minimum investment: $1K
- Investors: 17
- Date of first sale: 2017-07-17
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-314371
Issuer
- Name: PeproMene Bio, Inc.
- CIK: 0001742221
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2016
- Address: 200 SPECTRUM CENTER DR. SUITE 4034, IRVINE, CA, 92618
- Phone: (949) 564-4085
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Young Rae Choi | Director | Irvine, CA |
| Sun Tae Hwang | Director | Irvine, CA |
| Hong Woo Kim | Director | Irvine, CA |
| Hyukjong Tae Lee | Director | Irvine, CA |
| Yung Ki Park | Director | Irvine, CA |
| Hong Woo Kim | Executive Officer | Irvine, CA |
| Yung Ki Park | Executive Officer | Irvine, CA |
More